Clinical Trial Update: Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections [Phase 3]

View source ↗

Summary

Phase 3 clinical trial exploring cefepime and Unictam to prevent post-cesarean surgical site infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Infections
• Surgical Site Infection

Drugs mentioned

• Cefepime (cefepime)
• Unictam

Snippet

Sponsor: Beni-Suef University | Conditions: Cesarean Section; Infection | Phase 3 | Status: UNKNOWN